The Prostate Cancer Outcomes Registry – Australia and New Zealand (PCOR-ANZ) is an important initiative to monitor and benchmark the quality of treatment and care of men diagnosed with prostate cancer across Australia and New Zealand.
Aims and Objectives
The primary aim of PCOR-ANZ is to develop a population-based prostate cancer clinical registry to assist in improving the quality of care provided to men with prostate cancer. PCOR-ANZ will improve knowledge of prostate cancer, advance treatment options and identify whether gaps exist in service provision by:
- monitoring, benchmarking and publicly reporting on the outcomes of prostate cancer treatment and care
- providing risk adjusted, evidence based data to clinicians, hospitals and decision makers on prostate cancer clinical practice that fosters and evaluates improved quality of treatment and care for men diagnosed with prostate cancer
- monitoring trends in incidence of prostate cancer in populations and survival over time
- determining the clinical effectiveness of treatments in a real world setting
- identifying factors that predict favourable and unfavourable treatment outcomes, particularly in relation to the major adverse effects
- providing information to patients about the risks and benefits of specific approaches to prostate cancer treatment
- fostering research leading to improvement in care and survival; ideally enabling comparisons across countries
|Adding New Patients to Registry
To participate, please contact your jurisdiction Registry Coordinator.
For men to participate in the Prostate Cancer Outcomes Registry – Australia & New Zealand (PCOR-ANZ) they must:
- be aged 18 years or over
- have a current or previous diagnosis of prostate cancer
- have been diagnosed or treated for prostate cancer in a participating hospital